Translational Therapy

The Translational Therapy Shared Resource (TTSR) accelerates the transition of novel cellular and immune-based therapies from the lab to the clinic by facilitating the monitoring of clinical trials and overcoming manufacturing hurdles. The TTSR encompasses two major components: the cGMP-compliant Molecular and Cellular Therapeutics facility for bioproduct manufacturing, and the Translational Therapy Laboratory for central processing, immune monitoring, and biorepository management of clinical trial samples.